Simcere Pharmaceutical Group Limited

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023

In its 2023 reporting, Simcere Pharmaceutical Group Limited disclosed greenhouse gas emissions of 67.6K tCO2e/year. By scope: Scope 1: 5.0K tCO2e/year; Scope 2: 62.6K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
67.6K tCO2e/year
2023
💧
Water Usage
1.2M tonnes/year
2023
♻️
Waste
4.0K tonnes/year
2023
⚙️
Energy Use
80.1M kWh/year
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).5.0K tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.62.6K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Lower greenhouse gas emissions per RMB 10,000 of revenue by no less than 10% by 2025.
  • Lower water consumption per RMB 10,000 revenue by no less than 10% by 2025.
  • Lower purchased electricity consumption per RMB 10,000 of revenue by no less than 10% by 2025.
  • Lower solid waste discharge per RMB 10,000 revenue by 15% by 2025.

🌱 ESG Focus Areas

ESG governanceCorporate governanceInnovation benefiting the publicQuality assuranceTalent constructionLow-carbon operationCaring society

⚠️ Challenges & Risks +

  • Tightened climate change policies increasing the cost of compliant operation.
  • Changes in market demand for more environmentally friendly and low-carbon products.
  • Stakeholders' concerns demanding higher response requirements in terms of climate issues.
  • Extreme weather events causing damage to operating assets and equipment.
  • Long high-temperature periods increasing energy consumption.
  • Water shortage increasing operating costs.
  • Trade secret and intellectual property protection risk.
  • Post-marketing medical research risk.
  • Data security and compliance risk.
  • Business ethics risk.

📋 Report Information

Reporting Period: 2023
Frameworks: Appendix 27 Environmental, Social, and Governance Reporting Guide of the Main Board Listing Rules of the Hong Kong Exchanges and Clearing Limited (HKEX)